The tweet was deleted by the author.
But we saved everything 🙂.
West Pharmaceutical Services is urging stakeholders in the pharmaceutical sector to update contamination control strategies, as the United States Pharmacopeia (USP) releases draft chapters 1110 and 1114.
These drafts introduce the next era of risk-based contamination control strategies (CCS), signaling substantial changes in regulatory expectations. Industry participants are encouraged to review their current protocols to remain compliant and competitive as new guidelines emerge.
The sector's response to evolving regulatory standards will likely influence not only compliance but also future recognition for excellence, as demonstrated by West Pharmaceutical Services' achievements in securing top supplier and innovation awards in drug delivery. In addition, collaborative industry engagement, reminiscent of West's recent initiatives to connect with experts at the BIO China event, may prove essential in navigating the transition to these updated contamination control protocols.